12-27368390-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020183.6(BMAL2):c.160G>A(p.Gly54Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,613,956 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020183.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BMAL2 | NM_020183.6 | c.160G>A | p.Gly54Arg | missense_variant | 2/17 | ENST00000266503.10 | NP_064568.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMAL2 | ENST00000266503.10 | c.160G>A | p.Gly54Arg | missense_variant | 2/17 | 1 | NM_020183.6 | ENSP00000266503.5 | ||
BMAL2 | ENST00000457040.6 | c.94G>A | p.Gly32Arg | missense_variant | 1/15 | 1 | ENSP00000400185.2 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000795 AC: 20AN: 251428Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135882
GnomAD4 exome AF: 0.000181 AC: 265AN: 1461866Hom.: 0 Cov.: 30 AF XY: 0.000160 AC XY: 116AN XY: 727238
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152090Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.160G>A (p.G54R) alteration is located in exon 2 (coding exon 2) of the ARNTL2 gene. This alteration results from a G to A substitution at nucleotide position 160, causing the glycine (G) at amino acid position 54 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at